Filing Details

Accession Number:
0001415889-21-000969
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-25 20:00:06
Reporting Period:
2021-02-23
Accepted Time:
2021-02-25 20:00:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-23 7,353 $0.00 57,936 No 4 A Direct
Common Stock Disposition 2021-02-25 1,803 $106.68 56,133 No 4 S Direct
Common Stock Disposition 2021-02-25 96 $107.70 56,037 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. On April 12, 2019, the Reporting Person was granted a performance-based Restricted Stock Units (the "RSUs") covering 14,706 shares of common stock, vests in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 23, 2021, the milestones were satisfied for the vesting of RSUs covering 7,353 shares of common stock.
  2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1.